To determine whether loss of Casq2 only in Purkinje cells is sufficient to induce a CPVT phenotype, we tested arrhythmia susceptibility in our selective Casq2–/– models. The gene discussed is CASQ2; the disease is catecholaminergic polymorphic ventricular tachycardia.